SPRO — Spero Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapTurnaround

Annual balance sheet for Spero Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	146	109	76.3	52.9	40.3
Net Total Receivables	2.64	1.08	50.7	52.5	25.4
Prepaid Expenses
Total Current Assets	158	114	131	107	67.3
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	7.56	5.49	4.16	3.11	1.48
Long Term Notes Receivable
Other Long Term Assets
Total Assets	171	125	182	111	68.9
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	18.7	21.6	37.2	49.1	8.87
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	82.8	48.9	75.5	64.4	9.9
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	88.3	75.9	107	46.1	59
Total Liabilities & Shareholders' Equity	171	125	182	111	68.9
Total Common Shares Outstanding
Total Preferred Shares Outstanding